Deals in Advanced Wound Care
Over the past three years the global Advanced Wound Care Market has almost doubled, an exciting market for investment according to SmartTRAK estimates. The biggest deal in Advanced Wound Care (AWC) has been Coloplast's acquisition of Kerecis in 2023. Kerecis, a startup in the US Skin Substitute Market, demonstrated strong growth and the potential to have a global presence, justifying the high price. Startups have been a key component of the market, with new technologies and products over the years, and have been advancing their portfolios through IPOs, strategic partnerships, and investments.
This downloadable article reviews the recent top deals and investment trends in AWC, including:
- Recent Global Wound Care Investments
- Top Deals and Investments Jan 2024 through June 2025
- Market Trends
- Although the US Skin Substitute/ CAMPs Market has seen exponential growth in the last few years, that isn't where global investment is occurring.
- Investment by Geography
- US and Canada Wound Care Investments
- UK, Europe, and Rest of World (ROW)
- Early-Stage Investments
- Non-Dilutive Funding Sources
- Strategic and Insurance Provider Investments
Want to know which deals are shaping the future of wound care? Click to access the full article, “Deals in Advanced Wound Care,” co-authored by Dr. Mitchell C. Sanders, CEO, ProDevLabs and Susan Paquette, SmartTRAK Senior Advisor, Wound, to get a firsthand look at the key investment trends driving this dynamic market.
